Nova Eye Medical Limited (EYE.AX)
Nova Eye Medical Limited operates in the Medical - Devices industry of the Healthcare sector, headquartered in Kent Town, SA, AU. The stock last traded at $0.15, up 0.00% on the session, giving a market capitalisation of $44.2M. Its beta of 0.93 implies it has historically moved less than the broad market.
Nova Eye Medical Limited specializes in the creation, advancement, distribution, marketing, sale, and servicing of surgical equipment dedicated to treating glaucoma. Its diverse product line features iTrack, a surgical system engineered to decrease intraocular pressure (IOP) in adult patients with open-angle glaucoma, and iTrack Advance, an innovative system promoting natural ocular fluid drainage. Furthermore, the company provides Molteno3, a glaucoma drainage device for individuals suffering from severe or intricate forms of the condition, alongside 2RT, a proprietary laser technology employed to address early to intermediate stages of age-related macular degeneration. With a presence spanning Australia, the United States, Europe, the Asia Pacific, and other international markets, the company, originally established in 1985 as Ellex Medical Lasers Limited, officially became Nova Eye Medical Limited in July 2020. Its corporate headquarters are situated in Kent Town, Australia.
Nova Eye Medical Limited is most often compared with the following Healthcare names: